 BOSTON and LAUSANNE, Switzerland, Dec. 29, 2021 GLOBE NEWSWIRE -- SOPHiA GENETICS SA Nasdaq: SOPH, announced today Chief Executive Officer and Co-Founder Dr. Jurgi Camblong and Chief Financial Officer Ross Muken, will participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference. The virtual presentation will begin at 8:15 a.m. ET2:15 p.m. CET on Tuesday, January 11, 2022 and will be available live and archived on SOPHiAGENETICS.COM, in the Investor Relations section. 